Pancreatic Cancer Research

ResearcherGuangdong Academy of Medical SciencesNo recent work listed

Ning Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8546-3802; OpenAlex author ID A5100651668. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper

Papers 3

  1. Score for predicting overall survival in pancreatic adenocarcinoma patients with positive lymph nodes after surgery: a novel nomogram-based risk assessment. Last author DOI 10.21037/gs-20-597↗
  2. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development. Co-author DOI 10.1111/jcmm.15125↗
  3. The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis. First author DOI 10.1186/s13014-020-01511-9↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yiping Zou · 3 shared papers, 2020–2021 · strength 0.38
  2. Haosheng Jin · 2 shared papers, 2020–2021 · strength 0.26
  3. Shiye Ruan · 2 shared papers, 2020–2021 · strength 0.26
  4. Liang Jin · 2 shared papers, 2020–2021 · strength 0.26
  5. Baohua Hou · 2 shared papers, 2020 · strength 0.24
  6. Yu Zhou · 1 shared paper, 2020 · strength 0.12
  7. Zhixiang Jian · 1 shared paper, 2020 · strength 0.12
  8. Chuanzhao Zhang · 1 shared paper, 2020 · strength 0.12
  9. Zi Yin · 1 shared paper, 2020 · strength 0.12
  10. Sheng Chen · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.